{"id":"W2108950758","doi":"10.1371/journal.pone.0114264","title":"Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational Studies","year":2014,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Calgary; Alberta Health Services","funders":"Novartis Pharmaceuticals Corporation; Pfizer","keywords":"Medicine; Sorafenib; Oncology; Internal medicine; Axitinib; Sunitinib; Renal cell carcinoma; Everolimus; Observational study; Cabozantinib; Retrospective cohort study; Cohort study; Progression-free survival; Overall survival; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02803587,0.00255759,0.01864009,0.008001284,0.0005409605,0.00312406,0.0024147,0.001961045,0.002226983],"category_scores_gemma":[0.05907562,0.001398283,0.03605061,0.007817719,0.0008531368,0.001684454,0.00140826,0.001752497,0.000202466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002865521,"about_ca_system_score_gemma":0.00346328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004566799,"about_ca_topic_score_gemma":0.01019391,"domain_scores_codex":[0.9716126,0.01611724,0.00743348,0.002224473,0.002179123,0.0004331453],"domain_scores_gemma":[0.9384107,0.04871751,0.00840921,0.001521501,0.00250599,0.000435187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001442492,0.00001962483,0.005345997,0.2040384,0.7821652,0.00009376631,0.00006632612,0.0005210402,0.0001398451,0.00010145,0.000245959,0.005819988],"study_design_scores_gemma":[0.0004357554,0.0001861726,0.003979674,0.01679994,0.9770938,0.00009234787,0.00004883793,0.0002256742,0.0001009644,0.0001668445,0.0008504107,0.00001955147],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008211353,0.9896645,0.0008081839,0.0001830219,0.0001230254,0.0002794914,0.0005324888,0.00001866952,0.0001792372],"genre_scores_gemma":[0.3527759,0.6389023,0.004115161,0.0008866907,0.0002853101,0.001461951,0.001322343,0.00003824749,0.0002120247],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9813599,"threshold_uncertainty_score":0.1482696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4248402098844387,"score_gpt":0.4084291344750627,"score_spread":0.01641107540937603,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}